Skip to content

Prognostic value of left ventricular global longitudinal strain combined with hypersensitivity troponin I in patients with septic cardiomyopathy

Prognostic value of left ventricular global longitudinal strain combined with hypersensitivity troponin I in patients with septic cardiomyopathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032128
Enrollment
Unknown
Registered
2020-04-20
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic cardiomyopathy

Interventions

Gold Standard:Clinical outcome
longitudinal&#32
combined&#32
with&#32
hypersensitivity&#32

Sponsors

Department of Critical Care Medicine, Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. Patients who meet the criteria of sepsis diagnosis or meet the requirements of sepsis shock. Sepsis 3.0 standard: the presence of infection, combined with the increase of SOFA score by 2 points or more. The shock criteria of sepsis were: hypotension (mean arterial pressure 2mmol / L which could not be corrected by active fluid replacement.

Exclusion criteria

Exclusion criteria: 1. Patients with previous cardiac dysfunction, factors that interfere with troponin I and echocardiography, and factors that seriously interfere with mortality. 2. The specific criteria are as follows: arrhythmia (atrial fibrillation, ventricular tachycardia, frequent ventricular premature, ventricular fibrillation, etc.), pregnancy, congenital heart disease, moderate and severe valve disease and valve replacement, as well as those patients with poor ultrasonic image quality, myocardial infarction, myocarditis, blood system diseases, long-term hormone therapy, and malignant tumors.

Design outcomes

Primary

MeasureTime frame
LV-GLS;hs-TnI;7-day mortality rate;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
28-day mortality rate;length of ICU staying;length of mechanical ventilation;length of CRRT;APACHE II;SOFA;qSOFA;LVDD;LVEDV;LVEF;E/Em;

Countries

China

Contacts

Public ContactJiangquan Yu

Northern Jiangsu People's Hospital

15651057659@163.com+86 18051060659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026